z-logo
open-access-imgOpen Access
Lupus Mastitis in Systemic Lupus Erythematosus: A Rare Condition Requiring a Minimally Invasive Diagnostic Approach
Author(s) -
Giacomo Lucivero,
Ciro Romano,
Franca Ferraraccio,
Andrea Sellitto,
Umberto De Fanis,
Riccardo E. Giunta,
Arthur V. Guarino,
Pasquale Pio Auriemma,
M. Benincasa,
Francesco Iovino
Publication year - 2011
Publication title -
international journal of immunopathology and pharmacology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.724
H-Index - 53
eISSN - 2058-7384
pISSN - 0394-6320
DOI - 10.1177/039463201102400435
Subject(s) - medicine , systemic lupus erythematosus , hydroxychloroquine , panniculitis , mastitis , biopsy , granulomatous mastitis , pathology , dermatology , disease , covid-19 , infectious disease (medical specialty)
Breast involvement is a rare event in SLE patients. The most frequent presentation is lupus panniculitis with skin erythema, tenderness, and parenchymal nodules. However, when breast masses are detected in SLE patients without significant superficial inflammation, it is mandatory to rule out breast carcinoma. Here, we report the case of a 47-year-old woman with an 18-year-long history of SLE, who presented with a suspicious breast mass. Since surgical trauma has been reported to be able to exacerbate breast inflammation in lupus mastitis, an ultrasound-guided minimally invasive Mammotome biopsy was performed to obtain tissue samples for histological and immunohistochemical examinations. Histology was consistent with lupus mastitis. The patient was already on mycophenolate mofetil and hydroxychloroquine. At the latest follow-up visit 6 years later, no progression of the breast lesion was observed.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom